Related Experiment Video
Updated: Aug 11, 2026

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
Published on: May 5, 2016
Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin
1Baystate Medical Center, Division of Infectious Diseases, 759 Chestnut St., Springfield, MA 01199, USA. daniel.skiest@bhs.org
Abstract:
Daptomycin, a new cyclic lipopeptide, was recently approved for the treatment of infections by gram-positive organisms, including infections with methicillin-resistant Staphylococcus aureus (MRSA). A patient infected with infected with MRSA developed resistance to daptomycin after prolonged exposure, which resulted in clinical failure. Clinicians should be aware of the possibility of daptomycin resistance and should consider routine testing for daptomycin susceptibility.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Treatment Resistant Cancers
Antimicrobial Effectiveness
Antibiotic Selection